Amit Akirov, MD, Author at Dermatology Advisor

Osmophobia May Be a Clinical Diagnostic Marker of Pediatric Migraine

By

Amit Akirov, MD

July 27, 2021

Study researchers evaluated the potential of osmophobia in as a clinical diagnostic marker of migraine in children and adolescents.

General Dermatology

Neurologic and Psychiatric Symptoms Common in COVID-19 Survivors

By

Amit Akirov, MD

June 17, 2021

Researchers strove to provide robust estimates of incidence rates and relative risks of neurologic and psychiatric diagnoses in patients in the 6 months following a COVID-19 diagnosis.

Practice Management

A Call for Action Against Racism in Patient Care

By

Amit Akirov, MD

May 24, 2021

This literature review explored the nature of racial bias in the clinical setting.

Psoriasis

Guselkumab Demonstrates Favorable Joint and Skin Efficacy Compared With Other Targeted Therapies in Psoriatic Arthritis

By

Amit Akirov, MD

May 20, 2021

Using a network meta-analysis, researchers compared guselkumab with targeted therapies for psoriatic arthritis for safety and joint and skin efficacy.

Psoriasis

GRAPPA 2020 Annual Meeting: Management of Psoriasis and Psoriatic Arthritis During the COVID-19 Pandemic

By

Amit Akirov, MD

April 6, 2021

A plenary session at the 2020 GRAPPA Annual Meeting was focused on the perspectives of the management of psoriasis and psoriatic arthritis during the COVID-19 pandemic.

Practice Management

The Effect of Opioid Dose and Route on Risk for Respiratory Depression

By

Amit Akirov, MD

March 22, 2021

The researchers’ goals were to evaluate the geographic differences of opioid administration and to examine how opioid administration was associated with respiratory depression.

Practice Management

Headache May Be an Early, Isolated Feature of COVID-19

By

Amit Akirov, MD

February 4, 2021

Headache may be an early symptom of COVID-19, and identifying patients with characteristic features may help provide early isolation and treatment.

General Dermatology

New Guidelines for the Management of Lyme Disease

By

Amit Akirov, MD

December 28, 2020

The Infectious Diseases Society of America, American Academy of Neurology, and American College of Rheumatology provided new clinical practice guidelines for Lyme disease prevention, diagnosis, and treatment.

General Dermatology

Psoriatic Arthritis and Rheumatoid Arthritis Have Similar Effect on Hand Function

By

Amit Akirov, MD

December 15, 2020

Researchers compared the effect of psoriatic arthritis and rheumatoid arthritis on objective and subjective parameters of hand function.

Psoriasis

Osteoarthritis Risk Higher Among Patients With Psoriatic Arthritis Than Psoriasis Alone

By

Amit Akirov, MD

December 14, 2020

Researchers assessed the risk for osteoarthritis in patients with PsA compared with those with psoriasis and the general population.

Amit Akirov, MD

All articles by Amit Akirov, MD

Osmophobia May Be a Clinical Diagnostic Marker of Pediatric Migraine

Neurologic and Psychiatric Symptoms Common in COVID-19 Survivors

A Call for Action Against Racism in Patient Care

Guselkumab Demonstrates Favorable Joint and Skin Efficacy Compared With Other Targeted Therapies in Psoriatic Arthritis

GRAPPA 2020 Annual Meeting: Management of Psoriasis and Psoriatic Arthritis During the COVID-19 Pandemic

The Effect of Opioid Dose and Route on Risk for Respiratory Depression

Headache May Be an Early, Isolated Feature of COVID-19

New Guidelines for the Management of Lyme Disease

Psoriatic Arthritis and Rheumatoid Arthritis Have Similar Effect on Hand Function

Osteoarthritis Risk Higher Among Patients With Psoriatic Arthritis Than Psoriasis Alone

Ixekizumab Leads to Earlier Skin Clearance Than Guselkumab in Patients With Moderate to Severe Psoriasis